Reinventing the Healing Power of Nitric Oxide Delivery.

Nu-Med Plus hospital nitric oxide delivery system on a wheeled cart

Builders of Next Generation Medical Devices

Nu-med Plus engineers patented technology to safely deliver precision doses of nitric oxide. A line of innovative systems are being developed to serve new patient populations. Nitric oxide is not nitrous oxide. Rather, nitric oxide is a naturally occurring molecule with life-saving properties. Delivered correctly, nitric oxide holds the potential to dilate constricted blood vessels in heart patients and heal respiratory complications in newborns. Our patented and patent-pending technology also explores the potential of nitric oxide to treat wound care and those suffering from malaria, COPD, tuberculosis and ARDS. Explore our products, pipeline, and join us in bringing this life-saving technology to new markets.

Nu-Med Plus portable nitric oxide delivery device

Lightweight & Portable
Nitric Oxide Delivery

This patented, battery-powered unit is designed to enable patient mobility inside a hospital and rapid deployment of nitric oxide beyond hospital walls. The Nu-Med Plus team engineered this portable nitric oxide delivery system to be worn comfortably by patients to allow ease-of-movement between critical care units. It also may allow treatment of patients who are not hospitalized but rather in emergency medical situations, underserved chronic therapies, and in developing nations.

Lowering Costs
= Opening Markets

Nu-Med Plus develops industry redefining products that are portable, cost less, operate more efficiently, and deliver user-friendly designs. These patented advancements break down barriers to open new markets deterred by the current prohibitive price and immobility of traditional nitric oxide delivery systems.

Innovative IP
= Competitive Edge

Nu-Med Plus has built out an intellectual property pipeline to revolutionize our industry. Our unmatched research and development team already earned one patent, and has two pending patents. Each patent is applied to follow our strategic goals of lowering costs and opening markets. Nu-Med strategic IP positioning allows for unimpeded growth while maintaining a strong defensive posture. Each piece offers new advances for clinicians and exceptional value for investors.

New Nitric Oxide Delivery = Nu-Med Plus

Nu-Med Plus brings the right team of experienced medical device executives, research and development leaders and innovative thinking to deliver a disruptive force in the nitric oxide delivery market. It all begins with a simple molecule and a life-saving promise. Nitric oxide’s unique property as a signalling molecule with one unpaired electron helped define its application to numerous conditions as a medical break through in the mid-1990's. We're still reinventing the healing powers of nitric oxide today and Nu-Med Plus is leading the way.

Nu-Med Plus medical device engineering illustration

Our Team

William Hayde

President | CEO

Mr. Hayde has been a Wall Street veteran for over 30 years, concentrating on investment banking and institutional trading, retiring from that portion of the industry after a long, successful career. Mr. Hayde has been the Managing Director of the Interim Opportunity Fund LLC and its advisor, Waterside Capital Advisors, Inc., since March 2018. During 2013, Mr. Hayde was a co-founder and Executive Vice-President of Intercontinental Beverage Capital, Inc. (“IBC”). IBC is a New York based merchant bank focused specifically on the beverage and consumer packed goods industries. Since January 2011 through March 2018 he served as Registered Vice President of Investment Banking Network 1 Financial Securities, Inc. and has held the following securities licenses: 4, 6, 7, 24, 55, 63 and 79. From 2002 through 2009 he was co-owner of Waterville Investment Research, which also operated the hedge fund Waterville Investment Partners LLP. Mr. Hayde maintains seats on the advisory boards of multiple public and private companies in the consumer and medical industries. From January 1997 through May 2010 he was head of investment banking for Brockington Securities and directed the firm’s underwriting activities, private placements, and initiation of trading of newly listed securities. Mr. Hayde received his B.A. degree from Stony Brook University.

Keith L. Merrell

Chief Financial Officer and Principal Accounting Officer, Secretary and Treasurer

Mr. Merrell serves as our Chief Financial Officer, Secretary and Treasurer. Mr. Merrell draws on over 35 years of accounting experience to manage our accounting functions and interface with our independent public accountants. He spent two years in the field of public accounting and has served as Chief Financial Officer for four other public companies. He currently serves full-time as our Chief Financial Officer and also serves as part-time CFO of another public company. His business career includes extensive experience in management, sales and marketing, consulting, and merger and acquisition work. He graduated from Arizona State University with a B.S degree in Accounting.

Fred Tejada

Director

Fred is a highly experienced professional geologist, with over 40 years of international experience in the mining industry, working with both major and junior mining and exploration companies in consultant or senior executive positions. He has been involved with a range of mineral projects, including gold, copper, nickel cobalt, and coal, across multiple regions such as Canada, Chile, Peru, Mexico, Portugal, the Philippines, the Balkans, and Fiji. Fred leads exploration activities, with many years of on the ground experience across the properties in Nova Scotia and New Brunswick.